WHO ICTRP trial
Investigation of cardiac metabolism in patients with heart failure using…
CTIS2024-515414-40-00 · EU Clinical Trials Information System · Recruiting
Key facts
| Trial ID | CTIS2024-515414-40-00 |
|---|---|
| Public title | Investigation of cardiac metabolism in patients with heart failure using hyperpolarized MRI |
| Scientific title | Clinical and pathophysiological aspects of visualization of metabolic flux in the failing human heart using hyperpolarized [1-13C]-pyruvate cardiac magnetic resonance |
| Primary sponsor | Region Midtjylland |
| Registry | EU Clinical Trials Information System |
| Recruitment status | Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): Yes Therapeutic exploratory (Phase II): Yes Therapeutic confirmatory - (Phase III): No Therapeutic use - (Phase IV): No |
| Countries | Denmark |
| Conditions | Heart failure;Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Diagnosis [E01];Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14] |
| Interventions | Product Name: Hyperpolarized [1-13C]pyruvate, Product Code:PRD10284730, Pharmaceutical Form: INJECTION, Other descriptive name: , Strength: |
| Registration date | Aug 30, 2024 |
| Target size | 30 |
| Secondary IDs | 2018-003533-15 |
| Registry page | euclinicaltrials.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: